No Data
No Data
CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching With Cutting-Edge Hi-C Technology
H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating
CareDx Showcases Latest Advancements Across Its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
CareDx Analyst Ratings
CareDx Faces Challenges Amid Disappointing Financial Performance and Overambitious Growth Targets, Warrants Sell Rating by Analyst
Goldman Sachs Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $35